Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease

Disease modifying drugs targeting β-amyloid.

American journal of Alzheimer's disease and other dementias·2012

Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report.

Journal of the neurological sciences·2008

Progranulin (PGRN) expression in ALS: an immunohistochemical study.

Journal of the neurological sciences·2008

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Neurology·2007

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Journal of neuropathology and experimental neurology·2002

Beta-amyloid, neuronal death and Alzheimer's disease.

Current molecular medicine·2002

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Coherent-state field-theoretic simulations of fluctuation-dominated reaction-diffusion systems.

The Journal of chemical physics·2026

Probing symmetry-driven DEA dynamics in ozone investigated by velocity slice imaging technique.

The Journal of chemical physics·2026

Kinetically constrained ring-polymer molecular dynamics extended to all regimes of electronic coupling.

The Journal of chemical physics·2026

Competition-Derived Relative Reactivity and 3D Electronic-State Analysis of Site- and Facial Selectivity in NaBH4/MeOH Ketone Reductions.

JACS Au·2026

Localized intrinsic bond orbitals decode correlated charge migration dynamics.

Chemical science·2026

HYPOXIC INTENSITY REVEALS DISTINCT CAROTID BODY O2 SENSING MECHANISMS.

American journal of physiology. Lung cellular and molecular physiology·2026

Related Experiment Videos

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease

Related Concept Videos

Disease modifying drugs targeting β-amyloid.

Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report.

Progranulin (PGRN) expression in ALS: an immunohistochemical study.

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Beta-amyloid, neuronal death and Alzheimer's disease.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Coherent-state field-theoretic simulations of fluctuation-dominated reaction-diffusion systems.

Probing symmetry-driven DEA dynamics in ozone investigated by velocity slice imaging technique.

Kinetically constrained ring-polymer molecular dynamics extended to all regimes of electronic coupling.

Competition-Derived Relative Reactivity and 3D Electronic-State Analysis of Site- and Facial Selectivity in NaBH4/MeOH Ketone Reductions.

Localized intrinsic bond orbitals decode correlated charge migration dynamics.

HYPOXIC INTENSITY REVEALS DISTINCT CAROTID BODY O2 SENSING MECHANISMS.

Related Experiment Videos

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease

Related Concept Videos

Related Articles